Pfizer Ltd share price logo

Pfizer Share Price

NSE: PFIZER

BSE: 500680

Small Cap

Healthcare Sector

5309.00

-32.00

(-0.60%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Pfizer Stock Performance

as on October 27, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹5,270
    ₹5,343
    downward going graph

    0.73%

    Downside

    0.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹3,701
    ₹5,993
    downward going graph

    30.29%

    Downside

    12.88%

    Upside

    downward going graph

Pfizer share price movements today

Previous Close
₹5,341.00
Open
₹5,341.00
Volume
11.06K
Upper Circuit
₹6,409.00
Lower Circuit
₹4,273.00
Day's Low - High
₹5,270 - ₹5,343
52 Week Low - High
₹3,701 - ₹5,993

Pfizer Historical Returns

1 Month Return
+ 8.88 %
3 Month Return
+ 0.76 %
1 Year Return
+ 1.38 %
3 Year Return
+ 21.95 %
5 Year Return
+ 3.89 %

Pfizer Fundamentals

as on October 27, 2025 at 4:01 pm IST

Market Cap

₹24,433.86 Cr

Return on Equity (ROE)

16.4

PE Ratio (TTM)

0

Return on capital employed (ROCE)

21.06

Beta (LTM)

0.38

P/B Ratio

4.34

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

27.23

EPS (TTM)

98.27

Sector

Pharmaceuticals

Book Value

301.97

Technical Analysis

Pfizer Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pfizer with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY24,433.860.78%0.00NANA
BUY10,852.20-8.77%0.524132,013
BUY63,574.347.33%0.603,48331,723
HOLD1,01,116.4527.46%0.614,61423,241
BUY63,601.2518.49%0.001,4146,445

Analyst Recommendation on Pfizer Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.67% of analysts recommend a 'BUY' rating for Pfizer. Average target price of ₹6483.33

Source: S&P Global Market Intelligence

Pfizer Share Price Target

Get share price movements and forecasts by analysts on Pfizer.

What analysts predicted

21.39%UPSIDE

Target Price

₹6483.33

Current Price

₹5309

Analyzed by

3 Analysts

High

₹7175

Target

₹6483.33

Low

₹5900

Pfizer target price 6483.33, a slight upside of 21.39% compared to current price of ₹5309. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Pfizer Stock’s Investor Sentiment and Interest

Search interest for Pfizer Ltd Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:36% versus previous 30 day period

Pfizer Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
621.75
572.64
531.36
575.21
539.97
546.63
562.86
588.59
537.99
591.91
603.05
Other Income
27.41
31.38
33.46
36.07
43.8
75.13
41.84
43.07
42.76
217.39
67.17
Total Income
649.16
604.02
564.82
611.28
583.77
621.76
604.7
631.66
580.75
809.3
670.22
Expenses
418.3
410.36
420.65
392.6
387.42
357.2
385.37
399.34
392
364.41
393.03
Operating Profit
203.45
162.28
110.71
182.61
152.55
189.43
177.49
189.25
145.99
227.5
210.02
Operating Profit Margin %
32.72%
28.34%
20.84%
31.75%
28.25%
34.65%
31.53%
32.15%
27.14%
38.43%
34.83%
Profit Before Interest, Tax and Depreciation
230.86
193.66
144.17
218.68
196.35
264.56
219.33
232.32
188.75
444.89
277.19
Interest
3.84
2.53
2.87
2.73
2.86
6.95
2.11
2.1
1.51
2.69
3.25
Depreciation
26.34
26.41
15.55
15.43
17.55
13.75
14.6
14.99
14.8
16.4
14.41
Profit Before Tax
200.68
164.72
125.75
200.52
175.94
243.86
202.62
215.23
172.44
425.8
259.53
Tax Paid
50.02
35.07
32.22
51.56
45.96
65
51.91
56.88
44.84
94.86
67.78
Profit After Tax
150.66
129.65
93.53
148.96
129.98
178.86
150.71
158.35
127.6
330.94
191.75
Total Net profit including share of profit / Loss from associate company
150.66
129.65
93.53
148.96
129.98
178.86
150.71
158.35
127.6
330.94
191.75
EPS
32.93
30.03
20.44
32.56
28.42
39.09
32.94
34.61
27.89
72.34
41.91
Actual EPS
32.93
30.03
20.44
32.56
28.42
39.09
32.94
34.61
27.89
72.34
41.91
Adjusted EPS
32.93
30.03
20.44
32.56
28.42
39.09
32.94
34.61
27.89
72.34
41.91
Diluted EPS
32.93
30.03
20.44
32.56
28.42
39.09
32.94
34.61
27.89
72.34
41.91

Pfizer Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,966.27
1,968.51
2,081.5
2,151.65
2,238.55
2,610.99
2,424.76
2,193.17
2,281.35
Other Income
231.59
114.29
167.39
184.02
81.12
62.65
134.05
188.46
345.06
Total Income
2,197.86
2,082.8
2,248.89
2,335.67
2,319.67
2,673.64
2,558.81
2,381.63
2,626.41
Expenses
1,617.14
1,468.22
1,516.3
1,579.09
1,526.43
1,775.26
1,615.9
1,557.87
1,541.12
Operating Profit
349.13
500.29
565.2
572.56
712.12
835.73
808.86
635.3
740.23
Operating Profit Margin %
17.76%
25.41%
27.15%
26.61%
31.81%
32.01%
33.36%
28.97%
32.45%
Profit Before Interest, Tax and Depreciation
580.72
614.58
732.59
756.58
793.24
898.38
942.91
823.76
1,085.29
Interest
0.96
0.42
1.29
10.85
15.11
10.49
13.39
15.41
8.41
Depreciation
62.93
66.25
71.39
103.24
109.41
115
105.51
62.28
60.79
Profit Before Tax
516.83
547.91
659.91
642.49
668.72
772.89
824.01
746.07
1,016.09
Tax Paid
180.05
187.84
230.86
133.36
171.11
160.33
200.08
194.74
248.49
Profit After Tax
336.78
360.07
429.05
509.13
497.61
612.56
623.93
551.33
767.6
Total Net profit including share of profit / Loss from associate company
336.78
360.07
429.05
509.13
497.61
612.56
623.93
551.33
767.6
EPS
73.61
78.7
93.78
111.28
108.77
133.89
128.5
120.51
167.79
Actual EPS
73.61
78.7
93.78
111.28
108.77
133.89
128.5
120.51
167.79
Adjusted EPS
73.61
78.7
93.78
111.28
108.77
133.89
128.5
120.51
167.79
Diluted EPS
73.61
78.7
93.78
111.28
108.77
133.89
128.5
120.51
167.79

Pfizer Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
345.48
328.82
331.8
97.81
323.18
427.33
667.08
355.68
256.84
659.75
Cash Flow from Investing Activities
-709.63
-254.18
-245.16
28.14
1,522.42
-468.84
-575.02
-36.05
53.7
-71.34
Cash Flow from Financing Activities
-61.88
-82.59
-110.35
-109.85
-163.52
-1,571.07
-180.51
-345.79
-235.14
-205.34
Net Cash Flow
-417.35
-3.46
-16.86
23.08
1,689.98
-1,612.58
-88.45
-26.16
75.4
383.07

Pfizer Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
63.92%
DII
14.93%
14.89%
14.89%
15.01%
15.15%
15.33%
15.84%
16.03%
16.79%
17.1%
17.23%
17.1%
FII
0%
0%
0%
2.82%
0%
3.33%
3.22%
3.54%
2.75%
2.18%
2.39%
2.6%
Public
18.38%
18.38%
18.37%
18.25%
17.9%
17.42%
17.01%
16.5%
16.54%
16.79%
16.45%
16.37%
Total Outstanding Shares
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
4,57,47,732
Total Shareholders
1,17,950
1,17,194
1,15,988
1,16,948
1,12,456
1,09,214
1,06,098
98,824
1,05,015
1,08,261
1,03,222
1,03,480

Mutual Funds that own Pfizer Stock

Check out the Mutual Funds with significant holdings in Pfizer.

Pfizer Corporate Actions

View detailed summary of the earnings and dividend history of Pfizer.

  • Pfizer Ltd Earnings Results

    Pfizer Ltd’s net profit jumped 27.23% since last year same period to ₹191.75Cr in the Q1 2025-2026. On a quarterly growth basis, Pfizer Ltd has generated -42.06% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Pfizer Ltd Dividends May,2025

    In the quarter ending March 2025, Pfizer Ltd has declared dividend of ₹35.00 per share on 19 May 2025 - translating a dividend yield of 1.22%.

    Read More about Dividends

Indices Featuring Pfizer Stock

Check stock indices that include Pfizer.

S&P BSE 250 SmallCap

₹6,920.86

0.68 (47.01%)

Nifty 500

₹23,840.90

0.65 (154.3%)

BSE Healthcare

₹44,860.14

-0.05 (-23.62%)

BSE 500

₹37,421.12

0.67 (249.21%)

S&P BSE 400 MidSmallCap

₹12,292.82

0.74 (89.72%)

Nifty Smallcap 250

₹17,330.15

0.65 (111.15%)

Nifty MidSmallcap 400

₹20,358.80

0.74 (149.8%)

BSE Small-Cap

₹53,788.82

0.51 (272.02%)

Insights on Pfizer Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 11.70% to 11.74% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.39% to 2.60% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PFIZER stock has moved up by 8.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.92% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 13.4% return, outperforming this stock by 12.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 123.9% return, outperforming this stock by 101.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 16.45% to 16.37% in Sep 2025 quarter

About Pfizer Ltd

Pfizer Limited is a leading pharmaceutical company that has been active in India since 1950, and has built up a strong portfolio with 43 manufacturing sites in 125 countries. They have 6 primary therapeutic areas including Oncology, Hospital Vaccines, Inflammation and Immunology, and have managed to keep up with cutting-edge technology with research and clinical trials. Over the years Pfizer Limited has seen many changes, from a Merger with ParkeDavis in 2002 and the closure of a manufacturing plant at Ankleshwar in 1999 to being the first company to introduce hormone replacement therapy and conjugated pneumococcal vaccines in India. In 2015 the plant located at Thane Belapur Road Navi Mumbai was transferred to a going concern with the sale to Vidhi Research and Development LLP, and in 2017 Pfizer acquired the brand Neksium with active ingredient Esomeprazole. The Goa plant was recognized with the India Manufacturing Excellence Award-Future Ready Factory of the Year Award 2017 and the Pfizer's President's Platinum Award for 2017. Pfizer Inc. USA, the Ultimate Holding Company, completed the transaction of combining its Upjohn Business with Mylan N.V. in 2019. Currently the company earns a revenue of Rs 176 Crore (nine months period ended in 2019) for their Corex brand, with Rs 244 Crore in profit for the financial year ending in 2016. Pfizer Limited continues to innovate and grow in the Indian market.

Revenue: ₹603.05Cr as on June 2025 (Q1 FY26)
Net Profit: ₹191.75Cr as on June 2025 (Q1 FY26)
Listing date: 09 Dec, 1994
Chairperson Name: Pradip P Shah
OrganisationPfizer Ltd
IndustryPharmaceuticals
CEOPradip P Shah
E-voting on sharesClick here to vote

FAQs

What is Pfizer share price today?

Pfizer share price today stands at ₹5309 as on at the close of the market. Pfizer share today touched a day high of ₹5343 and a low of ₹5270.

What is the 52 week high and 52 week low range for Pfizer share?

Pfizer touched a 52 week high of ₹5993 and a 52 week low of ₹3701. Pfizer share price today i.e. is closed at ₹5309, which is -11.41% down from its 52 week high and 43.45% up from its 52 week low.

What is Pfizer's market capitalisation today?

Pfizer market capitalisation is ₹24,433.86 Cr as on .

How to buy Pfizer shares?

To buy Pfizer shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PFIZER or Pfizer Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Pfizer shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Pfizer trading volume today?

Pfizer trading volume is 11.06K as on . This means that 11.06K shares of Pfizer were bought and sold on the stock market during today's trading session.